A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)
Phase of Trial: Phase I/II
Latest Information Update: 08 Feb 2019
At a glance
- Drugs Olaparib (Primary) ; Radium 223 chloride (Primary)
- Indications Adenocarcinoma; Bone metastases; Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 24 Jan 2019 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated
- 17 Apr 2018 Planned initiation date changed from 5 Apr 2018 to 5 Oct 2018.